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Abstract
Background: The closure of the abdomen after median laparotomy is still a matter of debate
among surgeons. Further well designed and performed randomised controlled trials determining
the optimal method of abdominal fascial closure are needed.
Design: This is a three armed, multi-centre, intra-operatively randomised, controlled, patient
blinded trial. Over 20 surgical departments will enrol 600 patients who are planned for an elective
primary abdominal operation. The objective of this study is to compare the frequency of abdominal
incisional hernias between two continuous suture techniques with different, slowly absorbable
monofilament materials and an interrupted suture using an absorbable braided suture material at
one year postoperatively.
Conclusion: This trial will answer the question whether the continuous abdominal wall closure
with a slowly absorbable material with longitudinal elasticity is superior to the continuous suture
with a material lacking elasticity and to interrupted sutures with braided thread.
Background
Median laparotomy is the most common technique of
abdominal incisions because it is simple, provides ade-
quate exposure to all four quadrants, is rapid to open and
usually bloodsparing [1]. A major problem after median
laparotomy remains the adequate technique of abdomi-
nal fascia closure. In prospective studies the incidence of
incisional hernias varies from 9% to 20% [2,3]. Wound
infection, obesity and suture closure technique are
addressed as major risk factors for the development of an
incisonal hernia [4,5].
Whereas patient related factors such as age, gender, body
mass index (BMI), underlying disease, co-morbidities,
prior surgical procedures and life-style factors (e. g. smok-
ing) cannot be controlled or standardised, the decisive
chance to lower the incidence of incisional hernias is to
optimise the surgical technique. Therefore, a great variety
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of suture materials and needles has been developed to
provide an adequate closure of the fascia and thus the
abdominal wall. Thousands of patients have been
included in trials in order to answer the question which is
the optimal method in abdominal fascia closure and
today a number of reviews and a meta-analysis are availa-
ble. However, the reliability of the existing evidence is
compromised by the low number of relevant randomised
controlled trials (RCT's) [6-8].
Therefore the discussion regarding the optimal technique
of abdominal fascia closure continues and most surgeons
practice according to their own experience rather than act-
ing evidence-based. This attitude resulted in an
unchanged frequency of incisional hernias over the last
decades [5]. None of the prior studies comparing rapidly
absorbable braided materials with interrupted sutures ver-
sus slowly absorbable monofilament suture materials in a
continuous technique were able to determine a definite
superiority for one technique. Possible reasons may be
small numbers of patients in each group or short follow-
up [9-12].
We therefore conclude that there is a lack of data from a
truly well-designed long-term trial performed in the daily
practice of surgery. This has led us to develop a large ran-
domised controlled trial comparing different surgical
techniques of abdominal closure after median laparot-
omy. INSECT is a multi-centre, intraoperatively ran-
domised controlled trial comparing three different
standardised surgical techniques with certain needle/
suture combinations on the occurrence of incisional her-
nia in patients with elective primary midline laparotomy.
Two groups will use running sutures with different longi-
tudinal elasticity (one group PDS™ and the other Mono-
Plus™) combined with an atraumatic needle and one
group interrupted sutures (Vicryl™) with a traumatic nee-
dle. A three-group parallel equivalence design was
selected because due to the results of the latest published
meta-analysis [11] the superiority for one closure method
has not been definitely proven. The randomisation proce-
dure will be done stratified for participating centers. The
planned sample size is at least 600 patients with a follow
up period of three years.
INSECT is the first large-scale trial that started after a
detailed theoretical and practical training of the partici-
pating surgical centers in March 2004 in order to reduce
surgical bias in the study. INSECT will provide internal
valid data for an adequate surgical technique of abdomi-
nal closure. Although we are well aware that this study
cannot answer all open questions, the results should help
to further improve evidence based surgery.
Design
Trial organization
INSECT has been designed and carried out by the Study
Centre of the German Surgical Society (SDGC). The SDGC
is an independent research group of the German Surgical
Society and the Medical School of the University of Hei-
delberg that has to design, conduct and analyse large ran-
domised surgical trials in order to improve daily surgical
practice. The role of the sponsor (BBD Aesculap) is limited
to material supply and local first-level-support. The spon-
sor is not involved in the database management and has
no access to the randomisation code.
Coordination
The trial is coordinated by the SDGC, which is responsible
for overall trial management, trial registration (Interna-
tional Standard Randomised Controlled Trial Number
(ISRCTN 24023541), http://www.controlled-trials.com),
database management, quality assurance including mon-
itoring, reporting and for the scientific program of all trial
related meetings.
Investigators
Patients will be recruited by over 20 surgical centres in
Germany. All investigators are hospital-based surgeons
with a focus on general surgery. In order to obtain a rep-
resentative trial result hospitals of all levels of care and
education (county/community, private and university
centres) are participating in this trial.
Adverse events committee
This committee consists of 3 surgeons and decides on the
final diagnostic classification of critical clinical events. For
all serious adverse events the documentation and relevant
patient data are verified by co-ordinating personnel of
each centre before submitting the data to the Adverse
Events Committee for diagnostic classification.
Burst abdomen, pulmonary infection and wound infec-
tion are secondary endpoints, but are also defined as
Adverse Events (definitions see table 1). Burst abdomen
and postoperative pulmonary infection will even be
always a Serious Adverse Event. The term Adverse Event
covers any sign, symptom, syndrome or illness that
appears or worsens in a patient during the period of obser-
vation in the clinical trial and that may impair the well-
being of the patient. The term also covers laboratory find-
ings or results of other diagnostic procedures that are con-
sidered to be clinically relevant. A Serious Adverse Event is
any adverse event that occurs at any time during the
period of observation, that results in death, is immedi-
ately life-threatening, requires or prolongs hospitalisa-
tion, results in persistent or significant disability or
incapacity.BMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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Analysis of safety related data is performed with respect to
frequency of:
• Serious Adverse Events and Adverse Events stratified by
body-system
• Adverse Events stratified by severity
• Adverse Events stratified by causality.
Study material supply
Study materials for all centres will be acquired by the BBD
Aesculap company. Each type of suture material derives
from a single batch to eliminate material inconsistencies.
All materials are delivered to the participating centres by
local representatives of the sponsor who also guarantee
local first-level-support.
On-site monitoring
During recruitment of patients each centre is monitored
on site according to good clinical practice (GCP) guide-
lines. The data monitoring for this trial will be performed
by an independent study nurse who is not involved in the
trial or in completion of the case report form (CRF). The
surgical monitoring will be done by independent sur-
geons being not involved in conducting this trial.
Ethics, Informed Consent and Safety
The final protocol was approved by the ethics committee
of the University of Heidelberg, Medical School. Second-
ary approval is gathered from all local ethics committees
responsible for the participating centres. Informed con-
sent will be obtained from each patient in oral and written
form before inclusion in the trial.
Patient selection
INSECT focuses on hospitalised patients over 18 years of
age who are planned for an elective primary abdominal
operation and are eligible for a vertical abdominal inci-
sion in order to perform the planned surgical procedure.
A detailed overview of all eligibility criteria is given in
Table 2.
Study objectives
The primary objective of this study is to compare the fre-
quency of incisional hernias between three different
abdominal fascia closure methods after one year postop-
eratively: two continuous slowly absorbable monofila-
ment suture materials with and without longitudinal
elasticity respectively (MonoPlus™ USP 1, 150 cm loop,
with a HRT-48 needle, BBD Aesculap Tuttlingen, Ger-
many and PDS II™ USP 1, 150 cm loop, Ethicon Norder-
stedt, Germany) and a interrupted suture with an
absorbable braided suture material (Vicryl™ USP 2, 6 × 45
cm, non-needled plus a traumatic needle, Ethicon Norder-
stedt, Germany).
Secondary objectives are the frequencies of early and late
onset complications such as burst abdomen, postopera-
tive pulmonary complications, wound infections and
incisional hernias after three years postoperatively. Addi-
tionally a set of surgical and non-surgical parameters
related to the operation will be analysed as secondary
objectives such as the frequencies of various complica-
tions, the lung function and the postoperative length of
hospital stay. A qualitative analysis is included in the
study to assess the relevance of the primary endpoint from
the patient's and the surgeon's perspective. The following
aspects are ranked in a descending order from 1 (= most
important) to 9 (= least important): postoperative com-
plication, intraoperative complication, length of hospital
stay, onset of enteral nutrition, death, postoperative pain,
postoperative fatigue, convalescence of the complete
physical maximum resilience and cosmetic result [13].
The ranking by the surgeon is done once for each surgeon
before the operation. Patients are completing the ranking
Table 1: Definition of early onset and late complications
Complication Definition
Burst abdomen Postoperatively missing continuity of the abdominal fascia in 
combination with a wound dehiscence with consecutive relapse 
operation.
Wound infection Redness, wound dehiscence with secretion either of putrid or caliginous, 
smelly fluid or requiring antibiotic treatment or surgical intervention.
Postoperative pulmonary complication Infection of the lung with either evidence of increased infection 
parameters (CRP > 2 mg/dl and/or leukocytes> 10 0000/ml) which are 
not caused by a different pathologic process or evidence of pulmonary 
infiltration in the chest x-ray, requiring antibiotic therapy.
Incisional hernia Postoperative evidence of a fascia dehiscence after completed superficial 
wound healing with or without prolapse of abdominal organs, confirmed 
by abdominal ultrasound.BMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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twice: first at inclusion and second at their discharge, to
investigate if the patient's initial perspective changes
within the hospital stay. Those various outcome parame-
ters will be evaluated as part of an additional scientific
project to build up a basis for further relevant questions in
abdominal wall closure.
Randomisation and surgical technique
A block-randomisation-list is generated via computer sys-
tem (SAS Version 8.2, SAS Institute Inc., Cary, USA) and
stratified for the individual centre. Each centre will con-
tribute 30 patients (10 to each group). The sealed ran-
domisation list is stored in the investigator file. Patients
are randomised using sealed opaque envelopes in the
operation theatre after the surgical procedure has been
started and before the abdominal wall will be closed.
Major challenge in this surgical trial compared to pharma-
ceutical trials is the standardisation of the surgical tech-
nique. All patients undergo a skin incision using electric
cautery. Upon completion of the surgical procedure, clo-
sure of the abdominal wall is performed in all three
groups in a standardised manner: four sharp Mikulicz-
Clamps are placed at the corners of the incision and in the
middle of the edges of the abdominal fascia and then the
closure technique will be performed according to ran-
domisation. Three groups are available: a continuous, all-
layer closure technique with either two monofilament
loops or an interrupted technique using a braided mate-
rial (material as described above). In all three groups
suturing is initiated at both ends of the incision towards
the middle, whereas the continuous suture line is overlap-
ping at the centre for at least 2 cm to secure each other (for
details see figure 1). Neither a subcutaneous closure nor a
subcutaneous drainage is to be inserted. Skin closure is
done with skin clips. Measurement of the length of scar in
centimeters (cm) is performed. A detailed description of
the required surgical technique is given in the INSECT-
study protocol enhanced by images and sketches as well as
video material used during the investigator meeting and
provided to all centres and investigators.
In an investigator meeting before trial initiation (March
5th – 6th, 2004, AESCULAPIUM, Tuttlingen, Germany) all
participating centres have been trained in the required
techniques using abdominal wall models of mini-pigs. An
evaluation of the investigator meeting was performed by
all participants and will be published shortly. Investiga-
tors being unable to attend were trained on-site using the
same training materials as in the investigator meeting.
Training materials were supplemented by videos demon-
strating the abdominal wall closure techniques (both con-
tinuous and interrupted) in the in vivo situation and in
the animal model giving all sub-investigators good insight
into the required techniques. Furthermore, a trial manager
of the SDGC is available and responsible for all trial
related issues and questions.
Blinding
The patient is blinded for the technique of abdominal
wall closure as the randomisation is performed intra-
operatively. The patient will remain blinded until the
assessment of the primary end-point at one year post-
operatively. If feasible within the infrastructure of the
Table 2: Eligibility Criteria
Inclusion criteria Exclusion criteria
• Age equal or greater than 18 years
• Expected survival time more than 12 months
• Patients undergoing primary and elective median laparotomy (patients 
with prior laparoscopy or abdominal operation via paramedian incision 
(e.g. appendectomy) may be included in the trial)
• BMI < 35
• Expected length of incision > 15 cm
• Patient must be able to give informed consent
• Patient has given informed consent
• Peritonitis
• Emergency surgery
• Participation in another intervention-trial with interference of 
intervention and outcome of this study
• Coagulopathy
A group of disorders of the blood clotting (coagulation) system in which 
bleeding is prolonged and excessive with abnormal values in the blood 
laboratory.
• Severe psychiatric or neurologic diseases
• Lack of compliance
• Drug- and/or alcohol-abuse according to local standards
• Current immunosuppressive therapy (more than 40 mg of a corticoid 
per day or azathioprin)
• Chemotherapy within 2 weeks before operation
• Radiotherapy of the abdomen completed longer than 8 weeks before 
operation
• Inability to follow the instructions given by the investigator or the 
telephone interviewer (insufficient command of language, dementia, lack 
of time)
• Lack of informed consentBMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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participating centre, observers should be independent and
not involved in completing the CRF and would thus also
be blinded for the used technique.
Follow up
Patients are observed for 30 days postoperatively for early
onset complications defined as secondary endpoints such
re-admittance for burst abdomen. One year after the oper-
ation the primary end-point will be assessed by docu-
menting the incidence of incisional hernia with a physical
examination and ultrasound of the abdominal wall. Fol-
low up is completed 3 years after the primary operation to
register any long-term complications of the used method
for abdominal wall closure and to document any late-
occurring hernias (see table 3 for detailed follow up).
Data management and quality assurance
Investigators enter data directly in paper-based case report
form (CRF). These are arranged for each visit time-point
and contain instructions and relevant definitions. All
treatments are recorded in treatment logs. Standard
adverse events forms are used to document (serious)
adverse events and relevant clinical procedures that have
been carried out. After verification of the data entered
according to "Good Clinical Practice" (GCP), one copy of
each completed CRF is sent by mail to the SDGC. A con-
current database is maintained there. All incoming CRF
are scanned to be electronically archived. Data are entered
in a specially developed relational data base management
system. The data entry module contains on-line range and
logical checks. For data that are found missing, illegible or
inconsistent, data clarification forms are generated which
are sent to the on-site monitor for resolution.
Certain events must be reported immediately by the inves-
tigator by fax on preprinted forms directly to the coordi-
nating centre. Examples are: informed consent and
randomisation form, serious adverse events and prema-
ture withdrawal form the trial. The reporting of serious
adverse events complies with national regulatory
requirements.
Statistical considerations and sample size estimation
Statistical methods are used to assess the quality of the
data, homogeneity of treatment groups, endpoints and
safety of the three different techniques.
Principles of continuous abdominal wall closure Figure 1
Principles of continuous abdominal wall closure. A Anchorage of the suture cranially/caudally outside the incision B 
Intersection of the loops in the middle of the incision C Knotting of each loop Images reprinted with courtesy of Mrs. B. Wiehn, 
BBD Aesculap, Tuttlingen GermanyBMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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The analysis is performed on the basis of an intention to
treat (ITT) population and with respect to ITT principles.
A patient belongs to the ITT population after the randomi-
sation. The primary endpoint will also be analysed on the
basis of a "per protocol" population.
To enable multiple comparisons in this three-armed study
the closed testing procedure will be used[14]. All three
treatment groups are considered separately without
assuming any pre-specified monotonic trend among
groups. All testing is done two-sided. The three elemen-
tary hypotheses address pairwise comparisons of the inci-
sional hernia rates R1, R2, and R3. These hypotheses H12:
R1 = R2, H13: R1 = R3, and H23: R2 = R3, are all contained in
the global null hypothesis H123: R1 = R2 = R3. Sample size
estimation, however, will be based on the elementary
hypotheses, thus leading to sufficient power in the global
test. Bauer had recommended that "sample sizes should
be chosen large enough to give a high chance of jumping
over the initial hurdle." [15].
The calculation of sample size is based on literature data,
as summarised most recently by van 't Riet et al [11]. With
interrupted suturing with an absorbable material, such as
Vicryl®, incisional hernias were seen in about 13% of
patients. This number is primarily based on the four-
armed trial by Wissing et al. [16]. With the use of slowly
absorbable materials, such as PDS®, MonoPlus®  or
Maxon®, lower herniation rates were found, but this holds
true only for continuous suturing. So far, only one trial
has compared fast and slowly absorbable materials for
interrupted sutures [17].
The comparison of interrupted rapidly absorbable versus
continuous slowly absorbable sutures has been the aim of
four previous studies. The results of these studies showed
Table 3: Flow Chart INSECT-Trial
Visit 1 
(=Screening)
2
(OP)
3
(day 2 post 
OP)
4
(day of 
discharge)
5
(6 months +/- 
1 month post 
OP)
6
(12 months +/- 
1 month post 
OP)
7
(three years 
after 
operation)
Extra-visit 
(secondary 
endpoint, AE 
or SAE)
Past medical 
history
X
Informed 
consent
X
Physical 
examination 
including the 
personal data
XX X
Basic study-
related 
examination I 
(for each 
secondary 
endpoint, AE, 
SAE)
X
(ranking of the 
patient before 
operation)
X
(ranking of the 
surgeon)
XX
(ranking of the 
patient after 
operation)
XX
(ranking of the 
patient after 
operation)
X
Basic study-
related 
examination II
X
Ultrasound of 
the abdominal 
wall
XX X
Lung function 
test
XX
Medication X X X X
Past medical history: past medical history, past surgical history, indication for operation, diabetes, renal insufficiency, smoking, lung disease
Personal data: gender, date of birth, height in cm, weight in kg
Basic study related examination I: physical examination for evaluation of all secondary endpoints including adverse events/serious adverse events 
where appropriate
Basic study related examination II: telephone visit of patient and/or practitioner and physical re-examination if necessary in case of unclear abdominal 
wall status
Physical examination: vital signs (blood pressure systolic/diastolic in mmHg, heartrate in /min), prior abdominal incisions, rectus diastasis
Ultrasound: standard abdominal wall investigation (if hernia present: length and width in cm)
Lung function test: FEV, vital capacity %BMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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a non-significant tendency towards a lower rate of inci-
sional hernia. Taking this data and the improved suture
properties into consideration, a hernia incidence of 4%
could be reasonably expected in one or both of the non-
Vicryl® groups over the first postoperative year. Smaller
differences are also unlikely to be of clinical relevance.
Assuming annual hernia incidences of 13% and 4% in at
least two of the groups, a raw sample size of 172 patients
per group can be calculated with a two-sided alpha of 0.05
and a beta of 0.20 (employing Fisher's exact test). We used
the PS power and sample size program of Dupont and
Plummer (Version 1.0.17) for sample size estimation
(freely available at: http://www.mc.vanderbilt.edu/
prevmed/ps.htm). To account for an estimated 10% loss
to follow-up and 2% surgical non-compliance with treat-
ment allocation, sample size should be increased to 200
patients per group. In summary, the trial should recruit a
total of 600 patients, with equal randomisation into the
three groups. Thus a total of 720 patients have to be
screened according to the CONSORT statement (Figure 2)
[18].
In the primary intention-to-treat analysis, testing will start
with the global null hypothesis H123: R1 = R2 = R3. Only if
this global test is significant at the 0.05 level, the three ele-
mentary hypotheses H12: R1 = R2, H13: R1 = R3, and H23: R2
= R3 will be tested next. These pairwise comparisons (Vic-
ryl® versus PDS®, Vicryl® versus MonoPlus®, and PDS® ver-
sus MonoPlus®) use the same alpha level of 0.05, because
closed test procedures in three-armed designs do not
require alpha level adjustment. If, however, the first
global hypothesis cannot be rejected at alpha level, the
family of elementary hypotheses will not be tested at all,
except for exploratory reasons.
To control for possible differences with regard to surgical
procedures (colorectal vs. gastric or pancreatic opera-
tions), centre, and surgical expertise (board-certified sur-
geon vs. assistant surgeon), logistic regression will be
used. We expect that the use of logistic regression will not
essentially comprise power assumptions when compared
to univariate testing. The inclusion of time-to-event data
in the primary statistical analysis (e.g. by applying Kaplan-
Meier-curves or Cox-regression) does not confer specific
advantages and seems unwarranted, also because an inci-
sional hernia causes similar consequences for the patient
irregardless of whether the hernia occurred after 3, 6 or 9
months.
Secondary endpoints, demographic and other variables
The analysis of the secondary endpoints and demographic
variables will be descriptive.
The description of continuous variables includes at least:
numbers of observations, mean, standard deviation,
median, minimum and maximum. The description of cat-
egorical variables (ordinal or nominal) includes at least
the number and percentage of patients belonging to the
relevant categories in the trial population as well as in
each treatment group.
The description of the ranking of parameters of interest
(patient's view before, after operation (day of discharge
and 12 months later) and surgeon's view) includes the
mean and median for each category in the trial popula-
tion. There will be a listing for all measurements taken for
the patients. In order to improve the presentation of the
observed data, graphical methods will be applied.
Closing of the clinical database and follow up database
The clinical database including all information until 12
months after the operation will be closed six months after
the last visit, complete documentation of all cases and res-
olution of all queries. At this time the primary endpoint of
the trial will be ascertained. The information of the final
follow-up three years after the operation will be added
later. This database will be closed three months after the
last telephone three years after the last operation.
Current status and planning
The initial idea and hypothesis for the study was devel-
oped in March 2003. After a systematic review of the liter-
ature according to Cochrane standards has been
performed the study protocol was completed in October
2003. The study protocol was approved by the local ethics
committee of the University of Heidelberg in December
2003. Preparation of all study and instructional materials
(including video clips) was completed in February 2004
and the first investigator meeting was held in Tuttlingen,
Germany on March 5th and 6th, 2004. In June 2004, fol-
lowing completion of contracts and approval of local eth-
ics committees, the first centres were initiated and the first
patient was recruited in July 2004. Currently 23 centres
are in an active status recruiting the required 30 patients
per centre. Further 6 centres are processed and will be acti-
vated within the next months. Assuming an enrolment of
5 patients per month and centre the end of recruitment is
assumed to be in October 2005.
Discussion
The strategy to publish study protocols in surgery and thus
to enhance transparency in a clinical trial might be rela-
tively new in surgery, but has been practised in other med-
ical fields for several years [19,20]. This mentioned
transparency increases reliability and validity of the
results when a detailed description of the experiment is
published prior to the conduction. The assumption how
many patients should be screened to include the sufficientBMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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INSECT-Trial according to CONSORT (Moher et al. Lancet 2001) Figure 2
INSECT-Trial according to CONSORT (Moher et al. Lancet 2001)BMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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number of patients based on the sample size calculation
needs to be transparent in order to evaluate whether
results from this trial are transferable to daily practice.
Therefore a flow chart according to the CONSORT state-
ment should be included in study protocols (Figure 1).
However, many important details of a randomised surgi-
cal trial are interesting to the reader and can not be pub-
lished together with the final results. It also seems out of
the question that medical journals that surgical trials
should be internationally registered [21].
INSECT is designed to help answering the question which
is the optimal method for abdominal wall closure.
Although there are a substantial number of randomised
studies and several meta-analyses examining different
techniques of abdominal fascia closure the optimal and
definite method for closing the abdomen has not yet been
found [6,7,11]. Therefore, the technique and materials for
abdominal wall closure are still determined by local mate-
rial supply and surgical tradition. These preconditions
and a detailed literature research gave us reason to design
a trial comparing three standardised common techniques
of abdominal fascia closure in abdominal surgery.
Several design features of INSECT were discussed before
the trial started. A two armed or a three armed study
design was debated before writing the protocol. As we
wanted to compare the clinically most relevant and most
evidence-based suture materials and suture techniques for
closure of midline abdominal incisions the most recent
and most relevant meta-analysis as a data-base for choos-
ing the different groups in our trial was used [11]. Two dif-
ferent suture techniques and materials became clear to
show the best results in abdominal fascia closure and
revealed the lowest incidence for incisional hernias:
slowly absorbable continuous (or running) sutures and
absorbable interrupted sutures. Aside from those two
groups of suture techniques (continuous versus inter-
rupted sutures) we included a third group using the same
technique as one of the other groups (continuous suture)
but using a different suture material (monofilament
suture with longitudinal elasticity) which is supplied by a
different company. INSECT depicts the surgical reality and
variety of abdominal wall closure as it compares not only
different suture techniques but also several suture
materials offered by different companies. Therefore, the
results of INSECT will be relevant for the majority of sur-
geons as the materials and techniques used in this trial are
widely accepted in daily use.
An important issue for a good trial is to define adequate
and well designed end-points. Regarding the optimal
method for abdominal closure a great variety of objectives
has to be considered: wound infection, wound dehis-
cence, incisional hernia, suture sinus, wound pain, etc.
The socio-economic and surgical most relevant objective
is the incidence of incisional hernias [4]. Because 50–70%
of incisional hernias will occur within one year after oper-
ation we selected the frequency of incisional hernias at
one year postoperatively as the primary end-point of our
study. All other relevant objectives such as wound infec-
tion, pain, pulmonary impairment, etc. were included as
secondary endpoints into the trial design. Additionally a
qualitative analysis for surgeons and patients was planned
to evaluate the importance of different outcome variables
between surgeons and patients.
A major challenge in this INSECT trial compared to other
studies, e. g. pharmaceutical trials, is the standardisation
of the surgical technique. Lack of standardisation in surgi-
cal trials is often an argument of opponents who state that
the achieved trial results would not be transferable to sur-
gical routine. Therefore all patients in the INSECT trial
undergo a standardised skin incision and opening of the
abdominal cavity as well as the closure of the abdominal
wall is performed in all three groups in a standardised
manner. To provide an overall highly standardised surgi-
cal procedure in every study site all participating centres
have been trained in the required techniques using
abdominal wall models of mini-pigs during an investiga-
tor meeting before trial initiation. For investigators who
were unable to attend the meeting training materials and
videos demonstrating the different abdominal wall clo-
sure techniques (both continuous and interrupted) used
in the study were provided. For further quality assurance
there will be a regular surgical monitoring during the trial.
Additionally, randomisation is stratified for each
individual centre and the trial results will be therefore
comparable among the different participating centres.
Conclusion
Over the last years, surgeons' attitude towards randomised
surgical trials has changed. It becomes more and more evi-
dent that surgical procedures could also be tested in ran-
domised studies. Surgical expertise is largely a personal
conviction and an apprenticeship with surgical tech-
niques passed from one surgical generation to the next
[6,22]. Most surgeons rather use particular techniques
because they are trained in than using the most evidence-
based technique. The Study Centre of the German Surgical
Society (SDGC) was founded 2003 in order to ensure that
surgical techniques are more evidence based and not sim-
ply the result of a surgical dogma. This is the first multi-
centre trial designed and conducted by the SDGC after a
special Study Group was founded. We are aware of the dif-
ficulties and problems of performing large surgical multi-
centre trials and, therefore, we decided to start with a trial
examining a fundamental, "simple" and daily performed
surgical technique. As the abdominal fascia closure is
largely based on tradition rather than evidence, the resultsBMC Surgery 2005, 5:3 http://www.biomedcentral.com/1471-2482/5/3
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of the INSECT trial will help to create more evidence and
to guide surgeons to a critical review of their surgical
routine.
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